R. Platt

First name
Middle name
Last name
Grandi, S. M., Vallee-Pouliot, K., Reynier, P., Eberg, M., Platt, R. W., Arel, R., et al. (2017). Hypertensive Disorders in Pregnancy and the Risk of Subsequent Cardiovascular Disease. Paediatr Perinat Epidemiol. http://doi.org/10.1111/ppe.12388
Eberg, M., Platt, R. W., & Filion, K. B. (2017). The Estimation of Gestational Age at Birth in Database Studies. Epidemiology. http://doi.org/10.1097/ede.0000000000000713
Grandi, S. M., Reynier, P., Platt, R. W., Basso, O., & Filion, K. B. (2018). The timing of onset of hypertensive disorders in pregnancy and the risk of incident hypertension and cardiovascular disease. Int J Cardiol. http://doi.org/10.1016/j.ijcard.2018.06.059
Abrahami, D., Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., et al. (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k4880
Mehrabadi, A., Reynier, P., Platt, R. W., & Filion, K. B. (2018). Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4621
Lefebvre, C. E., Filion, K. B., Reynier, P., Platt, R. W., & Zappitelli, M. (2019). Primary Care Prescriptions of Potentially Nephrotoxic Medications in Children with CKD. Clin J Am Soc Nephrol. http://doi.org/10.2215/cjn.03550319
Secrest, M. H., Platt, R. W., Reynier, P., Dormuth, C. R., Benedetti, A., & Filion, K. B. (2019). Multiple imputation for systematically missing confounders within a distributed data drug safety network: A simulation study and real-world example. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4876
Eberg, M., Platt, R. W., Reynier, P., & Filion, K. B. (2019). Estimation of high-dimensional propensity scores with multiple exposure levels. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4890
Secrest, M. H., Platt, R. W., Dormuth, C. R., Chateau, D., Targownik, L., Nie, R., et al. (2019). Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4708
Ayele, H. T., Reynier, P., Azoulay, L., Platt, R. W., Cabaussel, J., Benayoun, S., & Filion, K. B. (2020). Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort study. World J Urol. http://doi.org/10.1007/s00345-020-03429-z